Nicorette Inhalaattori (Nicotine)

The nicotine in the inhaler is absorbed through the oral mucosa and binds to nicotinic acetylcholine receptors in the brain. This activation releases dopamine and other neurotransmitters, reproducing the rewarding sensations of smoking and reducing the intensity of withdrawal, which helps the user maintain abstinence while tapering nicotine intake.

The appropriate dosing regimen is individualized and set by a qualified healthcare professional based on the patient’s smoking history, level of dependence, and response to therapy. The prescriber will decide the number of inhalations per day and any step‑down schedule, ensuring safe and effective nicotine replacement.

The safety of nicotine inhalation in pregnancy or while breastfeeding has not been definitively established. Because nicotine can cross the placenta and enter breast milk, the product should be avoided unless the potential benefit justifies the potential risk, and only after consultation with a healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team then provides pricing, availability, shipping details (including any temperature control requirements) and assists with import documentation.

Compared with nicotine patches or gum, the inhaler offers rapid oral‑mucosal absorption and a hand‑to‑mouth action that more closely resembles the ritual of smoking. This can improve satisfaction for some users, but it also may produce more throat irritation. Choice of product depends on individual preference, tolerance, and the clinician’s assessment of the most suitable delivery system.

The inhaler should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the device out of reach of children and avoid exposing it to extreme heat or freezing conditions, which could affect the integrity of the nicotine formulation.

The user places the mouthpiece of the inhaler in the mouth and gently inhales, allowing nicotine‑containing vapor to contact the oral mucosa. Each inhalation delivers a measured dose; the prescriber will advise the number of inhalations per day and any tapering schedule. The device is reusable, and the cartridge can be replaced according to the manufacturer’s instructions.

Serious risks include allergic reactions such as rash, swelling, or difficulty breathing, and cardiovascular events like chest pain, palpitations, or hypertension, especially in individuals with pre‑existing heart disease. Users should discontinue the inhaler and seek medical attention if any of these symptoms occur.

The inhaler is not recommended for individuals under 18 years of age, for non‑smokers, or for patients with known hypersensitivity to nicotine or any excipients in the device. It should also be avoided by patients with recent myocardial infarction, uncontrolled hypertension, or severe cardiovascular disease unless a physician determines that the benefits outweigh the risks.